Analyze Diet
Equine veterinary journal2004; 36(5); 426-430; doi: 10.2746/0425164044868413

Efficacy of oral and intravenous dexamethasone in horses with recurrent airway obstruction.

Abstract: Although the efficacy of dexamethasone for the treatment of recurrent airway obstruction (RAO) has been documented, the speed of onset of effect and duration of action are unknown, as is the efficacy of orally administered dexamethasone with or without fasting. Objective: To document the time of onset of effect and duration of action of a dexamethasone solution i.v. or orally with and without fasting. Methods: Protocol 1 used 8 RAO-affected horses with airway obstruction in a crossover design experiment that compared the effect of i.v. saline and dexamethasone (0.1 mg/kg bwt) on pulmonary function over 4 h. Protocol 2 used 6 similar horses to compare, in a crossover design, the effects of dexamethasone i.v. (0.1 mg/kg bwt), dexamethasone per os (0.164 mg/kg bwt) with and without prior fasting, and dexamethasone per os (0.082 mg/kg) with fasting. Results: Dexamethasone i.v. caused significant improvement in lung function within 2 h with a peak effect at 4-6 h. Dexamethasone per os was effective within 6 h with peak effect at 24 h at a dose of 0.164 mg/kg bwt prior to feeding. The duration of effect was, for all dexamethasone treatments, statistically significant for 30 h when compared to saline and tended to have a longer duration of effect when used orally. Dexamethasone per os at a dose of 0.164 mg/kg bwt to fed horses had mean effects comparable to dexamethasone at a dose of 0.082 mg/kg bwt per os given to fasted horses, indicating that feeding decreases bioavailability. Conclusions: Dexamethasone administered i.v. has a rapid onset of action in RAO-affected horses. Oral administration of a bioequivalent dose of the same solution to fasted horses is as effective as i.v. administration and tends to have longer duration of action. Fasting horses before oral administration of dexamethasone improves the efficacy of treatment. Conclusions: Oral administration to fasted horses of a dexamethasone solution intended for i.v. use provides an effective treatment for RAO-affected animals.
Publication Date: 2004-07-16 PubMed ID: 15253084DOI: 10.2746/0425164044868413Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study examines the effectiveness, onset, and duration of dexamethasone, administered both orally and intravenously, in treating horses with recurrent airway obstruction (RAO). It suggests that dexamethasone administered intravenously acts rapidly, while its oral administration to fasted horses also proves effective and tends to last longer.

Research Objective and Methods

  • The researchers aimed to document the onset time and duration of effect of dexamethasone given through intravenous (IV) injection or orally, combined with fasting or not. The effectiveness of dexamethasone as treatment for recurrent airway obstruction (RAO) in horses is already established, but these variables were previously unknown.
  • The study employed two protocols using RAO-affected horses with airway obstruction, testing both the effects of IV administration of dexamethasone versus saline solution, and comparing oral administration with various doses of dexamethasone with or without prior fasting. The duration and drying effect of the administered medication was tracked over specific periods of time.

Research Findings

  • The study found that intravenously administered dexamethasone showed notable improvements in lung function within two hours, with maximum effect appearing 4-6 hours after administration.
  • Orally administered dexamethasone was effective after six hours with the peak effect at 24 hours, when given a dose of 0.164 mg/kg body weight (bwt) before feeding. Additionally, it tended to have a longer-lasting effect when given orally, significantly affecting for up to 30 hours compared to saline.
  • The research also found that fasting horses before oral administration of dexamethasone improved the treatment effectiveness. The results suggest that feeding decreases the bioavailability of dexamethasone, pointing out that fed horses showed similar effects to fasted horses when given a lower oral dose.

Conclusions

  • The study concludes that intravenous administration of dexamethasone provides a quicker-onset treatment for horses affected by RAO. Simultaneously, oral administration to fasted horses was found to have a similarly effective, but longer-lasting effect.
  • These findings are beneficial as they provide more options for administering dexamethasone to horses, which could be helpful if a rapid response is needed, or if a longer-lasting effect is desired. They also propose that fasting horses prior to oral medication could enhance the treatment’s efficacy.

Cite This Article

APA
Cornelisse CJ, Robinson NE, Berney CE, Kobe CA, Boruta DT, Derksen FJ. (2004). Efficacy of oral and intravenous dexamethasone in horses with recurrent airway obstruction. Equine Vet J, 36(5), 426-430. https://doi.org/10.2746/0425164044868413

Publication

ISSN: 0425-1644
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 36
Issue: 5
Pages: 426-430

Researcher Affiliations

Cornelisse, C J
  • Pulmonary Laboratory, Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan 48824-1314, USA.
Robinson, N E
    Berney, C E A
      Kobe, C A
        Boruta, D T
          Derksen, F J

            MeSH Terms

            • Administration, Oral
            • Airway Obstruction / drug therapy
            • Airway Obstruction / veterinary
            • Animals
            • Biological Availability
            • Cross-Over Studies
            • Dexamethasone / administration & dosage
            • Dexamethasone / pharmacokinetics
            • Dexamethasone / therapeutic use
            • Dose-Response Relationship, Drug
            • Fasting / physiology
            • Female
            • Horse Diseases / drug therapy
            • Horses
            • Injections, Intravenous / veterinary
            • Male
            • Random Allocation
            • Recurrence
            • Treatment Outcome

            Citations

            This article has been cited 6 times.
            1. Adamič N, Prpar Mihevc S, Blagus R, Kramarič P, Krapež U, Majdič G, Viel L, Hoffman AM, Bienzle D, Vengust M. Effect of intrabronchial administration of autologous adipose-derived mesenchymal stem cells on severe equine asthma.. Stem Cell Res Ther 2022 Jan 21;13(1):23.
              doi: 10.1186/s13287-022-02704-7pubmed: 35063028google scholar: lookup
            2. Mainguy-Seers S, Lavoie JP. Glucocorticoid treatment in horses with asthma: A narrative review.. J Vet Intern Med 2021 Jul;35(4):2045-2057.
              doi: 10.1111/jvim.16189pubmed: 34085342google scholar: lookup
            3. de Wasseige S, Picotte K, Lavoie JP. Nebulized dexamethasone sodium phosphate in the treatment of horses with severe asthma.. J Vet Intern Med 2021 May;35(3):1604-1611.
              doi: 10.1111/jvim.16113pubmed: 33817859google scholar: lookup
            4. Pirie RS, Mueller HW, Engel O, Albrecht B, von Salis-Soglio M. Inhaled ciclesonide is efficacious and well tolerated in the treatment of severe equine asthma in a large prospective European clinical trial.. Equine Vet J 2021 Nov;53(6):1094-1104.
              doi: 10.1111/evj.13419pubmed: 33403727google scholar: lookup
            5. Lavoie JP, Bullone M, Rodrigues N, Germim P, Albrecht B, von Salis-Soglio M. Effect of different doses of inhaled ciclesonide on lung function, clinical signs related to airflow limitation and serum cortisol levels in horses with experimentally induced mild to severe airway obstruction.. Equine Vet J 2019 Nov;51(6):779-786.
              doi: 10.1111/evj.13093pubmed: 30854685google scholar: lookup
            6. Pearson W, Charch A, Brewer D, Clarke AF. Pilot study investigating the ability of an herbal composite to alleviate clinical signs of respiratory dysfunction in horses with recurrent airway obstruction.. Can J Vet Res 2007 Apr;71(2):145-51.
              pubmed: 17479778